The deregulation of this pathway can induce increased cell proliferation, the inhibition of apoptosis, the stimulation of angiogenesis, the promotion of tumor invasion/metastasis, and resistance to treatments such as anti-EGFR monoclonal antibodies [22,23,24,25,26]. Here, EGFR is linked to neoplasm.